Giulia Di Lullo - JoVE Visualize

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005

Membrane IgE binds and activates Fc epsilon RI in an antigen-independent mannerLuca Vangelista, Elisa Soprana, Michela Cesco-Gaspere, et al.

Stem Cell Reports|October 8, 2019

Stem Cell Modeling of Neuroferritinopathy Reveals Iron as a Determinant of Senescence and Ferroptosis during Neuronal AgingAnna Cozzi, Daniel I Orellana, Paolo Santambrogio, et al.

The Journal of Clinical Investigation|September 22, 2012

Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interfaceGiovanni Di Zenzo, Giulia Di Lullo, Davide Corti, et al.

Gut|July 3, 2023

Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cellsAlessia Potenza, Chiara Balestrieri, Martina Spiga, et al.

Nature Communications|January 8, 2026

TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strengthMartina Spiga, Alessia Potenza, Zulma Magnani, et al.

Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005

Membrane IgE binds and activates Fc epsilon RI in an antigen-independent mannerLuca Vangelista, Elisa Soprana, Michela Cesco-Gaspere, et al.

Stem Cell Reports|October 8, 2019

Stem Cell Modeling of Neuroferritinopathy Reveals Iron as a Determinant of Senescence and Ferroptosis during Neuronal AgingAnna Cozzi, Daniel I Orellana, Paolo Santambrogio, et al.

The Journal of Clinical Investigation|September 22, 2012

Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interfaceGiovanni Di Zenzo, Giulia Di Lullo, Davide Corti, et al.

Gut|July 3, 2023

Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cellsAlessia Potenza, Chiara Balestrieri, Martina Spiga, et al.

Nature Communications|January 8, 2026

TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strengthMartina Spiga, Alessia Potenza, Zulma Magnani, et al.

Pageof 2